Articles
Page 19 of 19
-
Citation: Journal of the International AIDS Society 2006 8:16
-
Nonopportunistic Neurologic Manifestations of the Human Immunodeficiency Virus: An Indian Study
HIV-1 is a neurotropic virus. In a resource-limited country such as India, large populations of affected patients now have access to adequate chemoprophylaxis for opportunistic infections (OIs), allowing them ...
Citation: Journal of the International AIDS Society 2005 7:2 -
Hypertriglyceridemia in Antiretroviral Therapy
Citation: Journal of the International AIDS Society 2005 7:65 -
Disease Progression Among Untreated HIV-Infected Patients in South Ethiopia: Implications for Patient Care
The natural course of HIV disease progression among resource-poor patient populations has not been clearly defined.
Citation: Journal of the International AIDS Society 2005 7:66 -
Initiating Antiretrovirals in a Resource-Constrained Setting: Does One Size Fit All?
Citation: Journal of the International AIDS Society 2005 7:67 -
Frequency of Drug-Resistant Variants of HIV-1 Coexistent With Wild-Type in Treatment-Naive Patients of India
Over the past few years, reports of emergence and transmission of drug-resistant strains of HIV have increased, especially in western countries. In the context of increased widespread use of zidovudine- and la...
Citation: Journal of the International AIDS Society 2005 7:68 -
Genetic Barriers to Resistance and Impact on Clinical Response
The development of drug resistance and cross-resistance continues to pose a challenge to successful long-term antiretroviral therapy despite the availability of new antiretroviral agents. The genetic barrier t...
Citation: Journal of the International AIDS Society 2005 7:69 -
Migration and Risk Factors for HIV Acquisition in Pregnant Women in Baja California, Mexico
Citation: Journal of the International AIDS Society 2005 7:69 -
Triple-Nucleoside Analog Antiretroviral Therapy: Is There Still a Role in Clinical Practice? A Review
The development and widespread clinical use of coformulated abacavir/lamivudine/zidovudine (ABC/3TC/ZDV) as Trizivir represented an important advance in the management of HIV-infected patients, especially those w...
Citation: Journal of the International AIDS Society 2005 7:70 -
Cytokine Profiles in Human Immunodeficiency Virus-Infected Children Treated With Highly Active Antiretroviral Therapy
There have been few longitudinal studies of cytokine production in neonatally acquired HIV-1 infection and none in Asian or Chinese children.
Citation: Journal of the International AIDS Society 2005 7:71 -
High Prevalence of Hepatitis B Virus Markers in Romanian Adolescents With Human Immunodeficiency Virus Infection
We evaluated the frequency of hepatitis coinfection in Romanian adolescents who were diagnosed with human immunodeficiency virus (HIV) infection prior to 1995.
Citation: Journal of the International AIDS Society 2005 7:68 -
Substitutions in the Reverse Transcriptase and Protease Genes of HIV-1 Subtype B in Untreated Individuals and Patients Treated With Antiretroviral Drugs
The nucleotide transition G→A is known as a hypermutation due to its high prevalence in HIV-1 and other pathogens. However, the contribution of the G→A transition in the generation of drug resistance mutations...
Citation: Journal of the International AIDS Society 2005 7:69 -
Prevalence and Correlates of HIV Testing: An Analysis of University Students in Jamaica
Prevention programs often promote HIV testing as one possible strategy of combating the spread of the disease.
Citation: Journal of the International AIDS Society 2005 7:70 -
The HIV-1 Non-subtype B Workgroup: An International Collaboration for the Collection and Analysis of HIV-1 Non-subtype B Data
Citation: Journal of the International AIDS Society 2005 7:71 -
eJIAS: The Journal of HIV/AIDS Science and Medicine in the Developing World
Citation: Journal of the International AIDS Society 2004 6:56 -
eJIAS: Editor's Welcome
Citation: Journal of the International AIDS Society 2004 6:58 -
eJIAS and the Bristol-Myers Squibb Foundation's Secure the Future Program
Citation: Journal of the International AIDS Society 2004 6:57